Arkolith/Insider Trading/CRBP/Form 4

Cohen Yuval

Chief Executive Officer, DirectorCorbus Pharmaceuticals Holdings, Inc. (CRBP) · full profile →Form 4 · filed Jun 18, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.0M
Net Open-Market Flow
-$3.0M
Transactions
22
15 non-derivative · 7 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 18, 2024Sell(S)2K$42.24$75K84K
Jun 18, 2024Option exercise(M)2K$4.26$10K87K
Jun 18, 2024Sell(S)12K$42.24$493K84K
Jun 18, 2024Sell(S)2K$42.24$98K84K
Jun 18, 2024Option exercise(M)12K$30.00$350K96K
Jun 18, 2024Sell(S)7K$42.24$303K77K
Jun 18, 2024Option exercise(M)2K$14.10$25K86K
Jun 17, 2024Option exercise(M)2K$4.26$8K86K
Jun 17, 2024Sell(S)9K$46.02$430K84K
Jun 17, 2024Sell(S)2K$46.02$81K84K
Jun 17, 2024Option exercise(M)9K$30.00$280K94K
Jun 14, 2024Option exercise(M)17K$14.10$237K101K
Jun 14, 2024Sell(S)17K$50.17$844K84K
Jun 14, 2024Option exercise(M)12K$4.26$53K97K
Jun 14, 2024Sell(S)12K$50.17$626K84K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 18, 2024Option exercise(M)2K—$031K
Jun 18, 2024Option exercise(M)2K—$050K
Jun 18, 2024Option exercise(M)12K—$00
Jun 17, 2024Option exercise(M)9K—$012K
Jun 17, 2024Option exercise(M)2K—$052K
Jun 14, 2024Option exercise(M)17K—$033K
Jun 14, 2024Option exercise(M)12K—$054K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-075071) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML